329 related articles for article (PubMed ID: 33013710)
1. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.
Dewailly D; Barbotin AL; Dumont A; Catteau-Jonard S; Robin G
Front Endocrinol (Lausanne); 2020; 11():641. PubMed ID: 33013710
[TBL] [Abstract][Full Text] [Related]
2. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
Dewailly D; Robin G; Peigne M; Decanter C; Pigny P; Catteau-Jonard S
Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
[TBL] [Abstract][Full Text] [Related]
3. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
Qi X; Pang Y; Qiao J
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
[TBL] [Abstract][Full Text] [Related]
4. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
[TBL] [Abstract][Full Text] [Related]
5. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone and polycystic ovary syndrome.
Bhide P; Homburg R
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():38-45. PubMed ID: 27103234
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
Zhang F; Liu XL; Rong N; Huang XW
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
[TBL] [Abstract][Full Text] [Related]
9. The regulation of the follicular synchronization and sensitivity of rats with PCOS by AMH during prolonged pituitary downregulation.
Huang J; Ding Y; Li Z
Gene; 2019 Dec; 721():144106. PubMed ID: 31499126
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
11. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women.
Stracquadanio M; Ciotta L; Palumbo MA
Gynecol Endocrinol; 2018 Mar; 34(3):223-228. PubMed ID: 28944702
[TBL] [Abstract][Full Text] [Related]
13. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
14. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Dimitrakova E; Malinova M; Mladenova M
Akush Ginekol (Sofiia); 2012; 51(6):22-6. PubMed ID: 23390860
[TBL] [Abstract][Full Text] [Related]
15. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
Du DF; Li XL; Fang F; Du MR
Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
[TBL] [Abstract][Full Text] [Related]
16. Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome.
Dumont A; Robin G; Dewailly D
Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):377-384. PubMed ID: 30299432
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells.
Pellatt L; Rice S; Dilaver N; Heshri A; Galea R; Brincat M; Brown K; Simpson ER; Mason HD
Fertil Steril; 2011 Nov; 96(5):1246-51.e1. PubMed ID: 21917251
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
19. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S
Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
